Argenx (ARGX)
(Delayed Data from NSDQ)
$365.81 USD
-10.79 (-2.87%)
Updated May 17, 2024 04:00 PM ET
After-Market: $366.18 +0.37 (0.10%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Brokerage Reports
argenex SE [ARGX]
Reports for Purchase
Showing records 41 - 60 ( 278 total )
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Vyvgart Hytrulos Value Proposition in CIDP Looks Like a Game-Changer; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Nothing Sticky About This Wicket, ADHERE''s a Success
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Takeaways From KOL Dinner Event on Navigating the anti-FcRn Competitive LandscapeThis report contains brief updates on the following: ARGX, IMVT. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Vyvgart Welcomes a Newcomer to the gMG Arena
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Additional Perspectives After Vyvgart Hytrulo Approval; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: argenex SE
Industry: Medical - Biomedical and Genetics
SubQ Efgartigimod Approval Arrives and ARGX-117 Provides Early Efficacy Signal; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Biotechnology- EHA 2023 Roundup for Covered Companies (Part 2)
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Takeaways From Our Conversation with argenxs Chief Scientific Officer; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
EHA 2023 Abstract Roundup for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Vyvgart Delivers Another Big Beat, What Else Is New? Raise PT to $494; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D